(marijuana stocks) What are your picks between Cronos, Canopy, Aurora, Aphria, others?
Posted Mar 12, 2018, 1:25 PM UTC
Posted Mar 12, 2018, 1:25 PM UTC
Like everyone else I like WEED, also have a lotto ticket on TGIF (sells in Vegas). I think US companies are now the under valued plays but could take awhile to get going.
TGIF is also my long-term lotto play. Current porfolio is about 75% WEED, 10% APH, 8% TGIF and the rest VFF/ICC
$MJ
| Company | Symbol | Price | Daily Change | 52W Change |
|---|---|---|---|---|
| ETFMG Alternative Harvest | MJ | 32.935 | -0.59% | +18.0% |
*[13-Week Price Moves](https://storage.googleapis.com/echoapollo-assets/charts/20180312 10h48-A59yx-linechart.png) - quote-bot by echoapollo
Good bot
Canopy and Aurora are the biggest players. Have one or the other. If this ends up being a very profitable brand-matters industry they will both do fine.
Aphria is the lowest-cost producer. If the marijuana market becomes very competitive they will be in the best shape.
Emblem has the best pharmaceutical pedigree and the best chance at something unique and patentable. But they could also fall flat as they have not been impressing lately.
Ianthus is the best positioned to profit from US state-by-state legalization. They sell consulting services to marijuana companies rather than growing or selling themselves.
So I have a spread over $TWMJF, $APHQF, $EMMBF, and $ITHUF. I like that better than the whole industry cap-weighted fund. But there would be nothing wrong with just getting the ETF if that's more your speed.
I own Canopy and Aurora, but they all seem to be solid. I picked my 2 because a) Canopy is the biggest name out there and Bruce Linton just oozes a calm confidence that I love and b) ACB is aggressive af and they're thirsty. I got in a year ago and I haven't really been disappointed.
$WEED and $APH, safe bets for the long term, especially $APH which is currently under pressure due to an up-coming international spin-off. Low risk. medium return.
$TRST (CannTrust). Positive EBITDA, large facility opening up (already paid for), and an agreement with Apotex (pharma company) already in place. Low risk, high return.
$ICC (ICC Labs). Low cost producer in Uruguay with deals with many other countries (including Canada through EMH). A huge amount of up-side. Medium risk, high return.
$MPX (MPX). US play, risky, they need cash. High risk, high return.
$OGI.WT.A (OGI Warrants, expiry June 2019, $4 strike. No acceleration clause). Massive up-side. OGI tanked on bad weed a year ago, but they are back on-track and doing well. High risk, high return.
| Company | Symbol | Price | Daily Change | 52W Change |
|---|---|---|---|---|
| Trustco Bank Corp N Y | TRST | 8.95 | 0.0% | +13.3% |
| Amphenol Corporation | APH | 92.83 | +0.42% | +31.6% |
| Marine Products Corp | MPX | 15.08 | -1.11% | +50.5% |
*[13-Week Price Moves](https://storage.googleapis.com/echoapollo-assets/charts/20180312 12h40-CqRCv-linechart.png) - [52 Week Price Change](https://storage.googleapis.com/echoapollo-assets/charts/20180312 12h40-CqRCv-barchart.png) - quote-bot by echoapollo
Most estimates have the Canadian Marijuana industry somewhere around $6.2 billion. The combined market cap of the top 24 Canadian Cannabis stocks are over $26 Billion. Assuming the black market instantly dies, small boutique growers get 0% market share and there are no legislative challenges, that puts the top 24 marijuana index at around 4 times sales. Some estimates say marijuana could be a really profitable business with margins as high as 12% (Which is inline with high end retailers like Starbucks). This puts the big 24 at around 34x earnings. So even assuming every possible thing that can go right goes right that puts a pretty big premium on these stocks for no other reason other than the fact they have first-to-market advantage. Marijuana is going to be brutally competitive. There's not a lot of upside at these levels. i'm out.
I believe that the entire marijuana industry combined will not add up to one dollar in overall profit. I would compare it to the airline industry of old that as a whole burned billions and billions of dollars of capital. There will be some version of southwest that always makes a profit, but profits will not be as high as most investors expect. We will go from under-supply to oversupply very quickly and this will become another commodity business with razor thin margins. Most gullible of all are the investors that think weed companies with valuations of ~ $5 billion or more will be making them a lot of money moving forward.
Canopy Growth for sure. They have global facilities ready to roll when legalization hits. Infrastructure already in place ready for distribution, just waiting on legislation.
$HMMJ is an ideal choice. I'd love another major pullback on these to invest more.
My pick order: Canopy (75% of my weed portfolio atm), Aph, Aurora, Cronos. Aphria is the only one of the big 5 with profitable EPS and has a much lower P/E ratio. Cronos had a massive runnup recently with the NASDAQ listing so not a great time to buy. ACB has a lot of dilution going on but they are still a top 3-5 pick. If you're really unsure you could always buy HMMJ.
APH undervalued atm
Wouldn't say undervalued, but it does have potential
I went for the largest (Canopy) and the ETF (HMMJ).
Are you me? good choices. :)